Division of IQVIA
Latest From Quintiles Inc.
Public Company Edition: Long-struggling Regulus is laying off employees and pausing its two clinical programs. Also, Ironwood is shuffling staff ahead of splitting into two companies and will cut 40 jobs in the process. And among several loan agreements and note sales, Tesaro borrows another $200m.
Dianbo Liu, chairman of the Hong Kong listed Luye Group, talks about the company’s ambitious plans to become a global top 100 pharmaceutical company through innovation, acquisitions and overseas expansion, and to broaden its activities well beyond selling medicines to meet changing patient needs and industry pressures.
Biopharma executives were hammered on drug pricing during the JP Morgan conference in January; now they've back in San Francisco and appear prepared to strike back with a united message: all stakeholders must work together.
Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.
- Contract Research, Toxicology Testing-CRO
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Senior Management
- Pam Kirby, PhD, CEO
- Contact Info
Phone: (919) 998-2888
5927 S. Miami Blvd.
P.O. Box 13979 Durham, NC 27703
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.